ZYNERBA PHARMACEUTICALS INC (ZYNE)

US98986X1090 - Common Stock

1.3  +0.03 (+2.36%)

After market: 1.3015 +0 (+0.12%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
38.79M35.25M36.77M52.06M34.32M
Research and Development
24.75M21.10M21.42M35.65M20.38M
Selling, General, and Administrative Expenses
14.03M14.15M15.35M16.41M13.94M
Operating Income
-38.79M-35.25M-36.77M-52.06M-34.32M
Interest Income/Expense
1.20M215.73K-538.63K730.00K1.38M
Income Before Taxes
-37.58M-35.04M-37.31M-51.34M-32.94M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-37.58M-35.04M-37.31M-51.34M-32.94M
EBITDA
-38.56M-35.03M-36.52M-51.85M-34.19M
 
Per Share Data
EPS Diluted Total Ops
-0.80-0.82-0.95-1.90-1.50
Non GAAP EPS
-0.80-0.83-0.93-1.95-1.87
 
Statistics
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts